Little Green Pharma Ltd (LGP) Earnings Call Transcripts

Little Green Pharma Ltd's Latest Earnings Call - May 22, 2026

In the reconvened general meeting held on May 22, 2026, Little Green Pharma Ltd (LGP:AU) focused on the proposed merger with Cannatrek. The key resolution, which involves the issuance of up to 713,597,312 consideration securities, was recommended for approval by the Board. The merger is set to complete on June 1, 2026, pending court approval, which could significantly impact LGP's strategic direction and market position in the health care sector.

Reported metrics

Guidance from management

Management indicated that following the merger, they will provide updates on integration and strategic plans, with a focus on expected synergies and cost savings.

What management said

Okay. Thank you. I now propose Resolution 1 put to the shareholders that pursuant to and in accordance with Listing Rule 7.1 and for all other purposes, shareholders approve the issue of up to 713,597,312 consideration securities to scheme shareholders or their respective nominees under the scheme, on the terms and conditions set out in the explanatory memorandum. The Board unanimously recommends that shareholders ...

Thank you. I now ask all shareholders in attendance that have not already voted and wish to do so to complete their poll form in accordance with the procedures outlined in the letter to shareholders and submit the completed poll form to cosec@lgp.global. [Voting]

What analysts pressed on

Analysts may be concerned about the potential risks associated with the merger, particularly regarding regulatory approvals and integration challenges. There were no specific questions raised during the meeting, indicating a lack of immediate concerns from shareholders.

Main topics on the call

• Merger with Cannatrek — The Board unanimously recommended that shareholders vote in favor of the merger with Cannatrek, stating, "if Resolution 1 is not approved... the company will not be able to implement the scheme." This merger is pivotal f...
• Shareholder Approval Process — The meeting confirmed that the necessary quorum was achieved, allowing the vote on Resolution 1 to proceed. The Board emphasized the importance of this resolution for the merger's implementation.
• Future Investor Briefing — Management indicated that following the merger's completion, an investor briefing will be scheduled to discuss the new leadership structure and strategic plans. This is expected to provide clarity on future operations an...
• Court Approval Timeline — The second and final court hearing for the merger is scheduled for June 1, 2026. Management expressed optimism about receiving court approval, which is crucial for the merger's execution.

Read the full Little Green Pharma Ltd transcript (May 22, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 12 Little Green Pharma Ltd earnings call transcripts on record, spanning January 31, 2023 to May 22, 2026. Based on this history, Little Green Pharma Ltd reports quarterly. The most recent call on file is dated May 22, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

LGP

Exchange

ASX

Country

AU

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

12

First call

January 31, 2023

Most recent

May 22, 2026

Reporting cadence

quarterly